Bausch Health Companies Inc. (TSX: BHC)
Canada
· Delayed Price · Currency is CAD
11.45
-0.03 (-0.26%)
Nov 21, 2024, 10:56 AM EST
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.51B USD in the quarter ending September 30, 2024, with 12.15% growth. This brings the company's revenue in the last twelve months to $9.47B, up 10.91% year-over-year. In the year 2023, Bausch Health Companies had annual revenue of $8.76B with 7.79% growth.
Revenue (ttm)
$9.47B
Revenue Growth
+10.91%
P/S Ratio
n/a
Revenue / Employee
$467.39K
Employees
20,270
Market Cap
4.22B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch + Lomb Corporation | 6.33B |
Curaleaf Holdings, Inc. | 1.83B |
dentalcorp Holdings Ltd. | 1.51B |
Tilray Brands, Inc. | 1.10B |
Sienna Senior Living Inc. | 867.55M |
WELL Health Technologies Corp. | 957.69M |
Cronos Group Inc. | 150.26M |
Extendicare Inc. | 1.42B |
Bausch Health Companies News
- 3 days ago - US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug - Reuters
- 3 days ago - Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis - Accesswire
- 3 days ago - PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS - Accesswire
- 7 days ago - Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs - Business Wire
- 21 days ago - Bausch Health Companies Inc. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 21 days ago - Bausch Health Companies, Inc. (BHC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Bausch Health raises 2024 revenue guidance - Seeking Alpha
- 21 days ago - Bausch Health Announces Third Quarter 2024 Results - Accesswire